215 related articles for article (PubMed ID: 18461672)
1. Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells.
Wang GL; Wen ZQ; Xu WP; Wang ZY; Du XL; Wang F
Croat Med J; 2008 Apr; 49(2):175-81. PubMed ID: 18461672
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
4. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
5. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
6. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
[TBL] [Abstract][Full Text] [Related]
7. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Li H; Ye X; Mahanivong C; Bian D; Chun J; Huang S
J Biol Chem; 2005 Mar; 280(11):10564-71. PubMed ID: 15653692
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
[TBL] [Abstract][Full Text] [Related]
9. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
11. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Mahanivong C; Chen HM; Yee SW; Pan ZK; Dong Z; Huang S
Oncogene; 2008 Feb; 27(9):1273-80. PubMed ID: 17724468
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic Acid Stimulates Urokinase Receptor (uPAR/CD87) in Ovarian Epithelial Cancer Cells.
Lizalek J; McKenna T; Huegel K; Marsh S; Carolan A; Kobliska A; Heying E; Gardner N; Miller G; Kotecki A; Henningsen M; Lundt A; Farley J; Ellerbroek SM
Anticancer Res; 2015 Oct; 35(10):5263-70. PubMed ID: 26408685
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.
Gil OD; Lee C; Ariztia EV; Wang FQ; Smith PJ; Hope JM; Fishman DA
Gynecol Oncol; 2008 Feb; 108(2):361-9. PubMed ID: 18073130
[TBL] [Abstract][Full Text] [Related]
17. Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator.
Li T; Jiang S
Pharm Biol; 2010 Feb; 48(2):161-5. PubMed ID: 20645833
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
Yamauchi A; Yamamura M; Katase N; Itadani M; Okada N; Kobiki K; Nakamura M; Yamaguchi Y; Kuribayashi F
BMC Cancer; 2017 Mar; 17(1):234. PubMed ID: 28359316
[TBL] [Abstract][Full Text] [Related]
19. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
20. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]